1120sek
-0,9 %
Date:2025-05-23Time:18:00:00Latest report:Q1-2025List:First NorthTicker:FLUI
Market Cap:15 msekEnterprise Value:6 msekNet Sales:1,77 msekEarnings:-10,3 msekEmployees:0ISIN:SE0023595459

Ratios

10-year key figure history for Fluicell turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Fluicell with index and moving average MA50 and MA200.

Stockprice:11,20
MA50:13,35
MA200:19,95
Price/MA200:-43,9 %
RSI (14):47,7
Price/MA50:-16,1 %

Description

Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.

Biotechnology